|
Video: What is a Stock Split?
|
|
Timber Pharmaceuticals is a clinical-stage biopharmaceutical company focused on the development and commercialization of treatments for orphan dermatologic diseases. Co.'s product candidates include: TMB-001, a topical formulation of isotretinoin using its IPEG delivery system for the treatment of moderate to severe subtypes of congenital ichthyosis, a group of rare genetic keratinization disorders that lead to dry, thickened, and scaling skin; and TMB-003, a proprietary formulation of Sitaxsentan, which is a selective endothelin-A receptor antagonist, and in preclinical development as an applied formulation for the treatment of sclerotic skin diseases. According to our Timber Pharmaceuticals stock split history records, Timber Pharmaceuticals has had 2 splits. | |
|
Timber Pharmaceuticals (TMBR) has 2 splits in our Timber Pharmaceuticals stock split history database. The first split for TMBR took place on May 19, 2020. This was a 1 for 12 reverse split, meaning for each 12 shares of TMBR owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 83.3333333333333 share position following the split. TMBR's second split took place on November 09, 2022. This was a 1 for 50 reverse split, meaning for each 50 shares of TMBR owned pre-split, the shareholder now owned 1 share. For example, a 83.3333333333333 share position pre-split, became a 1.66666666666667 share position following the split.
When a company such as Timber Pharmaceuticals conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.
Looking at the Timber Pharmaceuticals stock split history from start to finish, an original position size of 1000 shares would have turned into 1.66666666666667 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into Timber Pharmaceuticals shares, starting with a $10,000 purchase of TMBR, presented on a split-history-adjusted basis factoring in the complete Timber Pharmaceuticals stock split history.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
06/10/2015 |
|
End date: |
11/29/2023 |
|
Start price/share: |
$2,688.00 |
|
End price/share: |
$0.34 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
-99.99% |
|
Average Annual Total Return: |
-65.28% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$1.28 |
|
Years: |
8.48 |
|
|
|
Date |
Ratio |
05/19/2020 | 1 for 12 | 11/09/2022 | 1 for 50 |
|
|